Integrative genomic and transcriptomic analysis reveals genetic alterations associated with the early progression of follicular lymphoma
F Gao, H Liu, X Meng, J Liu, J Wang… - British Journal of …, 2023 - Wiley Online Library
Follicular lymphoma (FL), the most common indolent lymphoma, is a clinically and
genetically heterogeneous disease. However, the prognostic value of driver gene mutations …
genetically heterogeneous disease. However, the prognostic value of driver gene mutations …
DLBCL-associated NOTCH2 mutations escape ubiquitin-dependent degradation and promote chemoresistance
N Zhou, J Choi, G Grothusen, BJ Kim, D Ren, Z Cao… - Blood, 2023 - ashpublications.org
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin
lymphoma. Up to 40% of patients with DLBCL display refractory disease or relapse after …
lymphoma. Up to 40% of patients with DLBCL display refractory disease or relapse after …
Dissemination feature based on PET/CT is a risk factor for diffuse large B cell lymphoma patients outcome
Abstract Background 18F-FDG PET/CT provides precise information about dissemination of
lymphoma lesions. Dmax, defined as distance between the two lesions that were farthest …
lymphoma lesions. Dmax, defined as distance between the two lesions that were farthest …
Machine Learning Algorithms Identify Target Genes and the Molecular Mechanism of Matrine against Diffuse Large B-cell Lymphoma
Y Zhu, Z Ning, X Li, Z Lin - Current Computer-Aided Drug …, 2024 - ingentaconnect.com
Background: Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-
Hodgkin's lymphoma worldwide. Novel treatment strategies are still needed for this disease …
Hodgkin's lymphoma worldwide. Novel treatment strategies are still needed for this disease …
Development and validation of nomograms by radiomic features on ultrasound imaging for predicting overall survival in patients with primary nodal diffuse large B-cell …
H Deng, Y Zhou, W Lu, W Chen, Y Yuan, L Li… - Frontiers in …, 2022 - frontiersin.org
Objectives To develop and validate a nomogram to predict the overall survival (OS) of
patients with primary nodal diffuse large B-cell lymphoma (N-DLBCL) based on radiomic …
patients with primary nodal diffuse large B-cell lymphoma (N-DLBCL) based on radiomic …